“Optimized Second-Generation IL-4Rα Inhibition: Structural and Molecular Dynamics Properties of Rademikibart Fab-IL-4Rα Complex” (2024) SKIN The Journal of Cutaneous Medicine, 8(6), p. s452. doi:10.25251/skin.8.supp.452.